Peripheral arterial disease: A new challenge for HIV-infected patients;Enfermedad arterial periférica: un nuevo desafo para los pacientes con infección por el virus de la inmunodeficiencia humana

Medicina Clinica

Volumn 135, Issue 12, 2010, Pages 546-548

  Gutiérrez, Félix ^a   Masiá, Mar ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ARTERY DISEASE; ATHEROSCLEROSIS; EDITORIAL; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; TREATMENT RESPONSE;

EID: 77957578384     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2010.07.001     Document Type: Article

References (28)

1. C. Escolano, J. Ramos, F. Gutiérrez, M. Masi, I. Hernández, and C. Benito Cambios en el espectro de la morbilidad y la mortalidad de los pacientes con infección por el virus de la inmunodeficiencia humana ingresados en el hospital durante la era del tratamiento antirretroviral de gran actividad Med Clin (Barc) 122 2004 1 5
2. F. Gutiérrez, S. Padilla, M. Masi, J.A. Iribarren, S. Moreno, and P. Viciana Clinical outcome of HIV-infected patients with sustained virologic response to antiretroviral therapy: Long-term follow-up of a multicenter cohort PLoS ONE 1 2006 e89
3. V.A. Triant, H. Lee, C. Hadigan, and S.K. Grinspoon Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease J Clin Endocrinol Metab 92 2007 2506 2512
4. C. Grunfeld, J. Delaney, C. Wanke, J. Currier, R. Scherzer, and M. Biggs Preclinical atherosclerosis due to HIV infection: carotid intima-medial thickness measurements from the FRAM study AIDS 23 2009 1841 1849
5. E. Martínez, M. Larrousse, and J. Gatell Cardiovascular disease and HIV infection: host, virus, or drugs? Curr Opin Infect Dis 22 2009 28 34
6. M. Masi, S. Padilla, E. Bernal, M.V. Almenar, J. Molina, and I. Hernández Influence of antiretroviral therapy on oxidative stress and cardiovascular risk: a prospective cross-sectional study in HIV-infected patients Clin Ther 29 2007 1448 1455
7. S.W. Worm, C. Sabin, R. Weber, P. Reiss, W. El-Sadr, and F. Dabis Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study J Infect Dis 201 2010 318 330
8. A.C. Ross, N. Rizk, M.A. O'Riordan, V. Dogra, D. El-Bejjani, and N. Storer Relationship between inflammatory markers, endothelial activation markers, and carotid intima-media thickness in HIV-infected patients receiving antiretroviral therapy Clin Infect Dis 49 2009 1119 1127
9. M. Masi-Canuto, E. Bernal-Morell, and F. Gutiérrez-Rodero Alteraciones lipdicas y riesgo cardiovascular asociado a la terapia antirretrovrica Enferm Infecc Microbiol Clin 24 2006 637 648
10. E. Bernal, M. Masi, S. Padilla, and F. Gutiérrez High-Density Lipoprotein Cholesterol in HIV-Infected Patients: Evidence for an association with HIV-1 viral load, antiretroviral therapy status, and regimen composition AIDS Patient Care STDS 22 2008 569 575
11. M. Masi, S. Padilla, N. García, I. Jarrn, E. Bernal, and N. López Impaired endothelial function in HIV-infected patients with lipodystrophy Antivir Ther 15 2010 101 110
12. Friis-Møller N, Thibaut R, Reiss P, Weber R, Monforte AD, De Wit S, et al. Predicting the risk of cardiovascular disease in HIV-infected patients: the Data collection on Adverse Effects of Anti-HIV Drugs Study. Eur J Cardiovasc Prev Rehabil. 2010 Jun 10. [Epub ahead of print].
13. M. Masi, E. Bernal, S. Padilla, M.L. Graells, I. Jarrin, and M.V. Almenar The role of C-reactive protein as a marker for cardiovascular risk associated with antiretroviral therapy in HIV-infected patients Atherosclerosis 195 2007 167 171
14. A.C. Ross, R. Armentrout, M.A. O'Riordan, N. Storer, N. Rizk, and D. Harrill Endothelial activation markers are linked to HIV status and are independent of antiretroviral therapy and lipoatrophy J Acquir Immune Defic Syndr 49 2008 499 506
15. L.H. Kuller, R. Tracy, W. Belloso, S. De Wit, F. Drummond, H.C. Lane INSIGHT SMART Study Group Inflammatory and coagulation biomarkers and mortality in patients with HIV infection PLoS Med 5 2008 e203
16. F.J. Torriani, L. Komarow, R.A. Parker, B.R. Cotter, J.S. Currier, and M.P. Dub Endothelial function in human immunodeficiency virus-infected antiretroviral-nave subjects before and after starting potent antiretroviral therapy J Am Coll Cardiol 52 2008 569 576
17. A.T. Hirsch, Z.J. Haskal, N.R. Hertzer, C.W. Bakal, M.A. Creager, and J.L. Halperin ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease Circulation 113 2006 463 654
18. A.V. Doobay, and S.S. Anand Sensitivity and specificity of the ankle-brachial index to predict future cardiovascular outcomes: a systematic review Arterioscler Thromb Vasc Biol 25 2005 1463 1469
19. F.G. Fowkes, G.D. Murray, I. Butcher, C.L. Heald, R.J. Lee, and L.E. Chambless Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis JAMA 300 2008 197 208
20. F. Gutiérrez, E. Bernal, S. Padilla, I. Hernández, and M. Masi Relationship between ankle-brachial index and carotid intima-media thickness in HIV-infected patients AIDS 22 2008 1369 1371
21. D. Salas, J. Olalla, A. Del Arco, J. De La Torre, L. Prada, and M. Pombo Factores asociados a índice tobillo-brazo alterado en una cohorte de pacientes con VIH-1 Med Clin (Barc) 135 2010 533 536
22. E. Bernal, M. Masi, S. Padilla, I. Hernández, and F. Gutiérrez Low prevalence of peripheral arterial disease in HIV-infected patients with multiple cardiovascular risk factors J Acquir Immune Defic Syndr 47 2008 126 127
23. E. Selvin, and T.P. Erlinger Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 19992000 Circulation 110 2004 738 743
24. D. Periard, M. Cavassini, P. Taff, M. Chevalley, L. Senn, and C. Chapuis-Taillard High prevalence of peripheral arterial disease in HIV-infected persons Clin Infect Dis 46 2008 761 767
25. H.E. Resnick, R.S. Lindsay, M.M. McDermott, R.B. Devereux, K.L. Jones, and R.R. Fabsitz Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the Strong Heart Study Circulation 109 2004 733 739
26. L. Norgren, W.R. Hiatt, J.A. Dormandy, M.R. Nehler, K.A. Harris, F.G. Fowkes TASC II Working Group Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II) J Vasc Surg 45 Suppl S 2007 S5 S67
27. R. Palacios, I. Alonso, A. Hidalgo, I. Aguilar, M.A. Sánchez, and P. Valdivielso Peripheral arterial disease in HIV patients older than 50 years of age AIDS Res Human Retroviruses 8 2008 1043 1046
28. M. Masi, E. Bernal, S. Padilla, N. García, J.C. Escribano, and E. Martínez A pilot randomized trial comparing an intensive versus a standard intervention in stable HIV-infected patients with moderate-high cardiovascular risk J Antimicrob Chemother 64 2009 589 598